Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

191 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Skin Markers of Premature Ageing in Patients with COPD: Results Form COSYCONET.
Melzer T, Graf V, Kronseder A, Karrasch S, Kerschner M, Vogelmeier CF, Bals R, Alter P, Watz H, Fähndrich S, Behr J, Waschki B, Trudzinski FC, Jörres RA, Kahnert K. Melzer T, et al. Among authors: alter p. J Clin Med. 2024 Nov 19;13(22):6972. doi: 10.3390/jcm13226972. J Clin Med. 2024. PMID: 39598116 Free PMC article.
Midregional proatrial naturetic peptide (MRproANP) and copeptin (COPAVP) as predictors of all-cause mortality in recently diagnosed mild to moderate COPD-results from COSYCONET.
Fähndrich S, Herr C, Teuteberg S, Alter P, Söhler S, Soriano D, Classen J, Adams J, Weinhold V, Watz H, Waschki B, Zeller T, Eichenlaub M, Trudzinski FC, Michels JD, Omlor A, Seiler F, Moneke I, Biertz F, Stolz D, Welte T, Kauczor HU, Kahnert K, Jörres RA, Vogelmeier CF, Bals R; German COSYCONET Cohort. Fähndrich S, et al. Among authors: alter p. Respir Res. 2024 Jan 24;25(1):56. doi: 10.1186/s12931-024-02690-9. Respir Res. 2024. PMID: 38267944 Free PMC article.
Effects of triple therapy on disease burden in patients of GOLD groups C and D: results from the observational COPD cohort COSYCONET.
Zader JA, Jörres RA, Mayer I, Alter P, Bals R, Watz H, Mertsch P, Rabe KF, Herth F, Trudzinski FC, Welte T, Kauczor HU, Behr J, Walter J, Vogelmeier CF, Kahnert K. Zader JA, et al. Among authors: alter p. BMC Pulm Med. 2024 Mar 1;24(1):103. doi: 10.1186/s12890-024-02902-4. BMC Pulm Med. 2024. PMID: 38424530 Free PMC article.
Statins did not reduce the frequency of exacerbations in individuals with COPD and cardiovascular comorbidities in the COSYCONET cohort.
Frantzi N, Nguyen XP, Herr C, Alter P, Söhler S, Soriano D, Watz H, Waschki B, Trinkmann F, Eichenlaub M, Trudzinski FC, Michels-Zetsche JD, Omlor A, Seiler F, Moneke I, Biertz F, Rohde G, Stolz D, Welte T, Kauczor HU, Kahnert K, Jörres RA, Vogelmeier CF, Bals R, Fähndrich S; German COSYCONET Cohort. Frantzi N, et al. Among authors: alter p. Respir Res. 2024 May 15;25(1):207. doi: 10.1186/s12931-024-02822-1. Respir Res. 2024. PMID: 38750572 Free PMC article.
Midregional Proatrial Natriuretic Peptide (MRproANP) is associated with vertebral fractures and low bone density in patients with chronic obstructive pulmonary disease (COPD).
Trudzinski FC, Jörres RA, Alter P, Watz H, Vogelmeier CF, Kauczor HU, Thangamani S, Debic M, Welte T, Behr J, Kahnert K, Bals R, Herr C, Heußel CP, Biederer J, von Stackelberg O, Fähndrich S, Wouters EFM, Waschki B, Rabe KF, Herth FJF, Palm V; COSYCONET study group. Trudzinski FC, et al. Among authors: alter p. Respir Res. 2024 Jul 13;25(1):274. doi: 10.1186/s12931-024-02902-2. Respir Res. 2024. PMID: 39003487 Free PMC article.
Diffusion capacity and static hyperinflation as markers of disease progression predict 3-year mortality in COPD: Results from COSYCONET.
Pott H, Weckler B, Gaffron S, Martin R, Maier D, Alter P, Biertz F, Speicher T, Bertrams W, Jung AL, Laakmann K, Heider D, Wouters M, Vogelmeier CF, Schmeck B; COSYCONET Study Group. Pott H, et al. Among authors: alter p. Respirology. 2024 Oct 24. doi: 10.1111/resp.14843. Online ahead of print. Respirology. 2024. PMID: 39448064 Free article.
Association of Patients' Knowledge on the Disease and Its Management with Indicators of Disease Severity and Individual Characteristics in Patients with Chronic Obstructive Pulmonary Disease (COPD): Results from COSYCONET 2.
Fischer C, Siakavara M, Alter P, Vogelmeier CF, Speicher T, Pott H, Watz H, Bals R, Trudzinski F, Herth F, Ficker JH, Wagner M, Lange C, Stoycheva K, Randerath W, Behr J, Fähndrich S, Welte T, Pink I, Kahnert K, Seeger W, Kuhnert S, Gessler T, Adaskina N, Jörres RA. Fischer C, et al. Among authors: alter p. Patient Prefer Adherence. 2024 Dec 2;18:2383-2393. doi: 10.2147/PPA.S488165. eCollection 2024. Patient Prefer Adherence. 2024. PMID: 39650575 Free PMC article.
GOLD COPD Exacerbation History Categories and Disease Outcomes.
Waeijen-Smit K, Peerlings DEM, Jörres RA, Watz H, Bals R, Rabe KF, Vogelmeier CF, Speicher T, Spruit MA, Simons SO, Houben-Wilke S, Franssen FME, Alter P. Waeijen-Smit K, et al. Among authors: alter p. JAMA Netw Open. 2024 Dec 2;7(12):e2445488. doi: 10.1001/jamanetworkopen.2024.45488. JAMA Netw Open. 2024. PMID: 39693071 Free PMC article.
Chronic Airway Diseases Early Stratification (CADSET): a new ERS Clinical Research Collaboration.
Agusti A, Faner R, Donaldson G, Heuvelin E, Breyer-Kohansal R, Melén E, Maitland-van der Zee AH, Vestbo J, Allinson JP, Vanfleteren LEGW, van den Berge M, Adcock IM, Lahousse L, Brusselle G, Wedzicha JA; on behalf of the CADSET Clinical Research Collaboration; Current members of the CADSET Clinical Research Collaboration. Agusti A, et al. Eur Respir J. 2019 Mar 18;53(3):1900217. doi: 10.1183/13993003.00217-2019. Print 2019 Mar. Eur Respir J. 2019. PMID: 30886026 Free article. No abstract available.
191 results